Shire closing Owings Mills plant to focus on new drug deals - Puget Sound Business Journal (Seattle):

http://www.ecmalaysia.com/authors/author-1170.html
That is why the U.K. drug company is shuttinh its 50,000-square-foot Owings Mills plant and laying off 260 workersd over the next three Cabrey said. He could not say whether the $3 billion companyh is targeting any Maryland firmsfor purchase. Shire’sz desire to strike more deals comes amid a wave of mergeras among globaldrug companies. Last bought rival for $41 milliohn and bought for $68 billion in January. Shire is outsourciny the manufacturing done at the Owings Mills plant to a Nortj Carolinacontract manufacturer. Cabrey said the sour economy was not a facto inits decision.
Since buying the manufacturinvg facilityin 2002, Shire has investeed $65 million into the site and started with 150 people. The company’s drugs treat attention deficit and hyperactivity disorder, human genetic therapies, and gastrointestinal and renal diseases. Shire said it is working with Baltimorr County economic development officialw to market the facility to othetpharmaceutical companies. The manufacturing plant is locatednear , which is addintg a 60,000-square-foot building at the foot of its 80-acre Owingse Mills campus. The building will house 224 students by Stevenson spokeswoman Glenda LeGendre said the school is not interested in acquirinvg new landright now.
A manufacturing plant woulx be difficult to retrofit for a school she said.